Cannabinoid tetrad
The cannabinoid tetrad test screens pharmacological compounds that induce cannabinoid receptor-mediated effects. This preclinical model includes a series of four tests, i.e., behavioral components, which are spontaneous activity, catalepsy, hypothermia and analgesia.
Related Capabilities
-
ICH Core Battery, Central Nervous System, Abuse Liability
-
Cannabinoid tetrad
Abuse Liability -
Behavioral sensitization (hyperactivity)
Abuse Liability -
Abuse liability assessments: Self-administration
Abuse Liability